Jens Klotsche and colleagues shared new data at the 2021 EULAR congress analyzing the risk of uveitis events after discontinuing disease-modifying antirheumatic drugs (DMARD) in children with one of two JIA categories: extended oligoarthritis and rheumatoid factor (RF)-negative polyarthritis.
Many aging Americans can have their vision dimmed by cataracts, but the good news is that they're easily treated, one expert says.
Scientists in a European collaboration have shown that optic nerve stimulation is a promising neurotechnology to help the blind, with the constraint that current technology has the capacity of providing only simple visual signals. A new stimulation protocol of the optic nerve is a promising way for developing personalized visual signals.
Sitting behind a computer screen all day can strain your eyes, but do glasses that claim to block blue light really help?
Myopia is on the rise. In the UK, the number of children with myopia has doubled in the last 50 years. Globally, it's projected that by 2050 half of the world's population will be myopic.
Three of the most common chronic eye conditions require regular medical checkups and injections into the eye by ophthalmology specialists to keep looming blindness at bay. A study by the University of Bern and the Inselspital in collaboration with an AI in eyecare startup now demonstrates that patients' individual ideal frequency for these visits can quite accurately be predicted by machine learning—yielding a threefold benefit.
Researchers from the Universidad Carlos III de Madrid (UC3M) have created a mathematical model and simulated numerically the progression of age-related macular degeneration, one of the main causes of blindness.
A non-contact laser imaging system could help doctors diagnose and treat eye diseases that cause blindness much earlier than is now possible.
As children begin to return to their favorite sports, parents need to ensure that their youngsters use protective eyewear, a leading group of eye specialists says.
After receiving FDA approval for its IPL device, Lumenis Ltd. announced that it is launching OptiLight, a bright solution for dry eyes.